Cellectis S.A. Files Form 6-K
Ticker: CLLS · Form: 6-K · Filed: Jun 4, 2024 · CIK: 1627281
| Field | Detail |
|---|---|
| Company | Cellectis S.A. (CLLS) |
| Form Type | 6-K |
| Filed Date | Jun 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release
TL;DR
Cellectis dropped a 6-K with a press release on June 4th, check it for news.
AI Summary
Cellectis S.A. filed a Form 6-K on June 4, 2024, to report a press release dated June 4, 2024. The filing does not contain specific financial figures or operational details beyond the announcement of the press release.
Why It Matters
This filing indicates that Cellectis S.A. has made a public announcement, likely containing material information for investors, which is now accessible through the SEC.
Risk Assessment
Risk Level: low — The filing is a routine report of a press release and does not contain new financial data or significant operational changes.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- June 4, 2024 (date) — Filing and Press Release Date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report a press release issued by Cellectis S.A. on June 4, 2024.
What is the filing date of this report?
This report was filed on June 4, 2024.
Does Cellectis S.A. file annual reports under Form 20-F or 40-F?
Cellectis S.A. files annual reports under Form 20-F, as indicated by the checkmark in the filing.
What is the principal executive office address of Cellectis S.A.?
The principal executive office address of Cellectis S.A. is 8, rue de la Croix Jarry, 75013 Paris, France.
What exhibit is included with this Form 6-K?
Exhibit 99.1, a Press Release dated June 4, 2024, is included with this Form 6-K.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.4 · Accepted 2024-06-04 16:41:02
Filing Documents
- f6k_060424.htm (6-K) — 4KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-24-003282.txt ( ) — 13KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: June 4, 2024 /s/ Andr Choulika Andr Choulika Chief Executive Officer